- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Deerland Enzymes
Total 675 results
-
Genzyme, a Sanofi CompanyCompleted
-
Genzyme, a Sanofi CompanyTerminatedMesotheliomaGermany, Switzerland
-
Genzyme, a Sanofi CompanyCompletedCarcinoma, HepatocellularTaiwan
-
Genzyme, a Sanofi CompanyCompletedBiliary Tract Cancer | Gallbladder Cancer | Ampullary Carcinoma | Cancer Of The Extrahepatic Bile DuctItaly
-
Genzyme, a Sanofi CompanyCompletedAdvanced Breast CancerSouth Africa, Sweden, Hungary, Taiwan, Spain
-
Genzyme, a Sanofi CompanyCompletedLeukemia, Lymphocytic, Chronic, B-CellUnited States
-
Genzyme, a Sanofi CompanyCompletedNon-Small Cell Lung Cancer (NSCLC, Locally Advanced or Metastatic, Second-lineUnited States, Czech Republic, Hungary
-
Genzyme, a Sanofi CompanyCompletedBreast Neoplasms | Metastases, NeoplasmSpain, United States
-
Genzyme, a Sanofi CompanyCompletedB Cell Chronic Lymphocytic LeukemiaUnited States
-
Genzyme, a Sanofi CompanyCompleted
-
Genzyme, a Sanofi CompanyCompleted
-
Genzyme, a Sanofi CompanyCompletedSecondary HyperparathyroidismUnited States
-
Genzyme, a Sanofi CompanyCompletedRenal Failure | Secondary Hyperparathyroidism | Chronic Renal InsufficiencyUnited States, Puerto Rico
-
Genzyme, a Sanofi CompanyCompletedLymphoblastic Leukemia, Acute, ChildhoodUnited States
-
Genzyme, a Sanofi CompanyTerminatedIdiopathic Thrombocytopenic PurpuraUnited States
-
Genzyme, a Sanofi CompanyTerminatedNon-Hodgkin's LymphomaUnited States
-
Genzyme, a Sanofi CompanyTerminatedChronic Kidney Disease | HyperphosphatemiaGermany, Greece, Portugal, Austria, France, Hungary, Italy, Spain, Sweden
-
Genzyme, a Sanofi CompanyNo longer availableMultiple Myeloma | Non-Hodgkin's Lymphoma | Hodgkin's Disease
-
Genzyme, a Sanofi CompanyTerminatedChronic SinusitisUnited States
-
Genzyme, a Sanofi CompanyCompletedChronic Kidney DiseaseUnited Kingdom
-
Genzyme, a Sanofi CompanyCompletedCadaveric Donor Renal Transplantation | Acute Renal Allograft Rejection | Induction TherapyUnited States, France, Spain, United Kingdom, Germany
-
Genzyme, a Sanofi CompanyCompletedPeritoneal Dialysis | Chronic Kidney DiseaseBelgium, United Kingdom, Denmark, France, Italy, Netherlands, Spain
-
Genzyme, a Sanofi CompanyCompletedLiver Dysfunction | Transplantation, Liver | Rejection, TransplantUnited States, Canada
-
Genzyme, a Sanofi CompanyCompletedAcute Myelogenous Leukemia (AML) | Acute Lymphocytic Leukemia (ALL) | Graft vs. Host Disease (GvHD)United States, Canada
-
Genzyme, a Sanofi CompanyCompletedMusculoskeletal Diseases | OsteoarthritisFrance, Germany
-
Genzyme, a Sanofi CompanyCompletedGraft Rejection | Renal TransplantationUnited States
-
Genzyme, a Sanofi CompanyCompletedOsteoarthritisNetherlands, Germany, Italy
-
Genzyme, a Sanofi CompanyCompletedMelanomaUnited States
-
Genzyme, a Sanofi CompanyCompleted
-
Genzyme, a Sanofi CompanyCompletedGlycogen Storage Disease Type II | Acid Maltase Deficiency Disease | Glycogenosis 2 | Pompe DiseaseUnited States
-
Genzyme, a Sanofi CompanyCompletedModerate to Severe Chronic Plaque PsoriasisUnited States
-
Genzyme, a Sanofi CompanyCompletedFocal Segmental GlomerulosclerosisUnited States, Germany, United Kingdom, Italy
-
Genzyme, a Sanofi CompanyCompletedAcute Lymphoblastic LeukemiaJapan
-
Genzyme, a Sanofi CompanyCompletedMelanoma | Carcinoma, Renal CellUnited States
-
Genzyme, a Sanofi CompanyCompletedAcute Myelogenous LeukemiaJapan
-
Genzyme, a Sanofi CompanyCompletedLymphoma, Non-HodgkinUnited States, Canada
-
Genzyme, a Sanofi CompanyCompletedRenal ImpairmentUnited States
-
Genzyme, a Sanofi CompanyCompletedLymphoma, Non-Hodgkin | Multiple MyelomaUnited States
-
Genzyme, a Sanofi CompanyCompletedLymphoma, Non-Hodgkin | Multiple MyelomaCanada
-
Genzyme, a Sanofi CompanyCompletedGlycogen Storage Disease Type II (GSD-II) | Pompe Disease (Late-Onset) | Glycogenesis Type II | Acid Maltase Deficiency (AMD)United States, France, Canada, Netherlands, Australia
-
Genzyme, a Sanofi CompanyCompletedGlycogen Storage Disease Type IIUnited States, France, Germany, Israel, Italy, Netherlands, Taiwan
-
Genzyme, a Sanofi CompanyCompletedPompe Disease (Late-onset) | Glycogen Storage Disease Type II (GSD-II) | Acid Maltase Deficiency Disease | Glycogenosis 2Netherlands
-
Genzyme, a Sanofi CompanyApproved for marketingGlycogen Storage Disease Type II (GSD-II) | Acid Maltase Deficiency Disease | Glycogenosis 2 | Pompe Disease (Late-Onset)United States
-
Genzyme, a Sanofi CompanyCompletedGlycogen Storage Disease Type II | Glycogenosis 2United States
-
Genzyme, a Sanofi CompanyTerminatedOsteoporosisUnited States
-
Genzyme, a Sanofi CompanyCompletedGlycogen Storage Disease Type II | Acid Maltase Deficiency Disease | Glycogenosis 2 | Pompe DiseaseUnited States
-
Genzyme, a Sanofi CompanyCompletedPompe Disease Late-Onset | Glycogen Storage Disease Type II GSD IIUnited States
-
Genzyme, a Sanofi CompanyCompletedOsteoarthritis, KneeUnited States, Canada, France, Germany, United Kingdom
-
Genzyme, a Sanofi CompanyCompletedSolid Tumors | Leukemia, Myelocytic, Acute, Pediatric | Leukemia, Lymphocytic, Acute, Pediatric | Leukemia, Lymphocytic, Acute, Adult | Leukemia, Myelocytic, Acute, Adult | Myelodysplastic Syndromes, AdultUnited States
-
Genzyme, a Sanofi CompanyCompletedPompe Disease (Late-onset) | Glycogen Storage Disease Type II (GSD-II) | Acid Maltase Deficiency Disease | Glycogenosis 2France